CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
OPERATING ACTIVITIES:
Net income	$ 16,608,000	$ 17,422,000	$ 16,048,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	2,832,000	3,466,000	3,711,000
Amortization of intangible assets	117,000	154,000	191,000
Amortization of investment security discounts and premiums, net	419,000	1,140,000	1,142,000
Goodwill impairment	0	653,000	0
Loss on sale of premises and equipment	(148,000)	301,000	18,000
(Recovery) provision for credit losses	(1,479,000)	1,910,000	640,000
Stock based compensation	951,000	1,231,000	960,000
Securities losses (gains), available for sale	193,000	219,000	(699,000)
Originations of loans held for sale	(39,079,000)	(39,388,000)	(85,938,000)
Proceeds of loans held for sale	39,430,000	40,946,000	89,926,000
Gain on sale of loans	(1,046,000)	(1,131,000)	(2,474,000)
Net equity securities (gains) losses	(15,000)	146,000	40,000
Security trades payable	0	(111,000)	(1,455,000)
Earnings on bank-owned life insurance	(1,063,000)	(664,000)	(916,000)
Increase (decrease) in deferred tax asset	497,000	(681,000)	(359,000)
Other, net	605,000	(1,720,000)	(2,912,000)
Net cash provided by operating activities	18,822,000	23,893,000	17,923,000
Investment debt securities available for sale:
Proceeds from sales	24,702,000	5,557,000	17,947,000
Proceeds from calls, maturities and repayments	28,158,000	17,372,000	20,997,000
Purchases	(46,411,000)	(66,984,000)	(46,499,000)
Proceeds from sales of equity securities	35,000	0	0
Net increase in loans	(199,726,000)	(248,130,000)	(48,170,000)
Acquisition of premises and equipment	(806,000)	(377,000)	(1,137,000)
Proceeds from sale of premises and equipment	557,000	150,000	2,000
Proceeds from the sale of foreclosed assets	0	120,000	335,000
Purchase of bank-owned life insurance	(8,000)	(22,000)	(30,000)
Proceeds from bank-owned life insurance death benefit	1,656,000	2,000	825,000
Distribution of non-controlling interest	0	0	(25,000)
Investment in limited partnership	0	(695,000)	(1,070,000)
Proceeds from redemption of regulatory stock	41,739,000	11,282,000	3,143,000
Purchases of regulatory stock	(46,891,000)	(15,922,000)	(2,297,000)
Net cash used for investing activities	(196,995,000)	(297,647,000)	(55,979,000)
FINANCING ACTIVITIES:
Net increase (decrease) in interest-bearing deposits	80,923,000	(89,558,000)	81,869,000
Net (decrease) increase in noninterest-bearing deposits	(47,890,000)	24,703,000	45,003,000
Proceeds from long-term borrowings	180,000,000	0	0
Repayment of long-term borrowings	(30,000,000)	(23,000,000)	(30,000,000)
Net (decrease) increase in short-term borrowings	(7,423,000)	147,602,000	503,000
Finance lease principal payments	(185,000)	(180,000)	(165,000)
Dividends paid	(9,164,000)	(9,036,000)	(9,041,000)
Distributions to non-controlling interest	0	0	(17,000)
Issuance of common stock	9,041,000	394,000	408,000
Purchase of treasury stock	0	(700,000)	0
Net cash provided by financing activities	175,302,000	50,225,000	88,560,000
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	(2,871,000)	(223,529,000)	50,504,000
CASH AND CASH EQUIVALENTS, BEGINNING	40,333,000	263,862,000	213,358,000
CASH AND CASH EQUIVALENTS, ENDING	37,462,000	40,333,000	263,862,000
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Interest paid	33,420,000	7,196,000	9,157,000
Income taxes paid	3,021,000	3,001,000	4,236,000
Transfer of loans to foreclosed real estate	770,000	97,000	83,000
Right of use lease assets obtained in exchange for lessee finance lease liabilities	0	0	2,653,000
Recognition of low-income housing tax asset	0	3,873,000	0
Recognition of commitment on low-income housing project	0	3,873,000	0
Adoption of ASU 2016-13, financial instruments - credit losses non-cash impact	$ 1,647,000	$ 0	$ 0